US 9592291
Methods for iontophoretically treating nausea and migraine
granted A61KA61K31/42A61K41/0047
Quick answer
US patent 9592291 (Methods for iontophoretically treating nausea and migraine) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/42, A61K41/0047, A61K9/0009, A61K9/009